Gill Duchesne

Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial

Brett Delahunt, Judith D Murray, Allison Steigler, Chris Atkinson, David Christie, Gillian Duchesne, Lars Egevad, David Joseph, John Matthews, Christopher Oldmeadow, Hemamali Samaratunga, Nigel A Spry, John R Srigley, Hubert Hondermarck, James W Denham

Journal article  |  2020  |  Histopathology

AIMS: Perineural invasion (PNI) by prostatic adenocarcinoma is debated as a prognostic parameter. This study investigates the prog..

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial

David Joseph, James W Denham, Allison Steigler, David S Lamb, Nigel A Spry, John Stanley, Tom Shannon, Gillian Duchesne, Chris Atkinson, John HL Matthews, Sandra Turner, Lizbeth Kenny, David Christie, Keen-Hun Tai, Nirdosh Kumar Gogna, Rachel Kearvell, Judy Murray, Martin A Ebert, Annette Haworth, Brett Delahunt, et al.

Journal article  |  2020  |  International Journal of Radiation Oncology*Biology*Physics

Is adjuvant radiotherapy now history? Implications of the RAVES and RADICALS trial on current practice

M Pearse, A Kneebone, C Fraser-Browne, G Duchesne, A Herschtal, M Frydenberg, S Williams, D Fisher, J Tierney, C Vale, C Adrian, C Parker, M Parmar, M Sydes, S Chabaud, P Richaud, P Sargos

Conference Proceedings  |  2020  |  BJU INTERNATIONAL

A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP "RAVES" Trial

A Kneebone, C Fraser-Browne, W Delprado, G Duchesne, R Fisher, M Frydenberg, A Haworth, A Herschtal, DJ Joseph, TS Lim, JM Martin, JL Millar, M Sidhom, N Spry, CI Tang, S Turner, SG Williams, KL Wiltshire, H Woo, M Pearse

Conference Proceedings  |  2019  |  International Journal of Radiation Oncology*Biology*Physics

Effective and well tolerated: where do these drugs fit now?

Gillian M Duchesne

Journal article  |  2019  |  The Lancet Oncology

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

James W Denham, David Joseph, David S Lamb, Nigel A Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen-Hun Tai, David Christie, Lizbeth Kenny, Sandra Turner, Nirdosh Kumar Gogna, Terry Diamond, Brett Delahunt, Chris Oldmeadow, John Attia, Allison Steigler

Journal article  |  2019  |  The Lancet Oncology

Extracting tumour prognostic factors from a diverse electronic record dataset in genito-urinary oncology

Richard C Khor, Anthony Nguyen, John O'Dwyer, Gargi Kothari, Joseph Sia, David Chang, Sweet Ping Ng, Gillian M Duchesne, Farshad Foroudi

Journal article  |  2019  |  International Journal of Medical Informatics

Timing of Androgen Deprivation Therapy for Prostate Cancer Patients after Radiation: Planned Combined Analysis of Two Randomized Phase 3 Trials

DA Loblaw, J Bassett, C D'Este, G Pond, P Cheung, M Frydenberg, MT King, H Lukka, S Malone, JL Millar, RL Milne, T Pickles, R Smith, MR Stockler, S Turner, KH Tai, H Woo, G Duchesne

Conference Proceedings  |  2018  |  International Journal of Radiation Oncology*Biology*Physics

Trans Tasman Radiation Oncology Group Cancer Research: Phase III - Muscle Invasive Bladder Cancer trial (TROG 02.03): A moral dilemma

Nirdosh K Gogna, Gillian Duchesne, Peter O'Brien, Nigel Spry, Sandra Turner, John Matthews, Martin Borg, Kathryn Bauman, Madeleine King, Elizabeth Burmeister

Journal article  |  2018  |  Journal of Medical Imaging and Radiation Oncology

Using Online Meeting Software to Facilitate Geographically Dispersed Focus Groups for Health Workforce Research

Kristie L Matthews, Marilyn Baird, Gillian Duchesne

Journal article  |  2018  |  Qualitative Health Research

Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer

Amar U Kishan, Gillian Duchesne, Pin-Chieh Wang, Jean-Claude M Rwigema, Arun U Kishan, Christopher Saigal, Matthew Rettig, Michael L Steinberg, Christopher R King

Journal article  |  2018  |  American Journal of Clinical Oncology

Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?

Amar U Kishan, Gillian Duchesne, Pin-Chieh Wang, Jean-Claude M Rwigema, Christopher Saigal, Matthew Rettig, Michael L Steinberg, Christopher R King

Journal article  |  2018  |  American Journal of Clinical Oncology

Timing of androgen deprivation therapy for prostate cancer patients after radiation: Planned combined analysis of two randomized phase 3 trials.

Andrew Loblaw, Julie Bassett, Catherine D'Este, Gregory Russell Pond, Patrick Cheung, Jeremy Laurence Millar, Mark Frydenberg, Madeleine Trudy King, Himu Lukka, Shawn Malone, Roger L Milne, Tom Pickles, Rosemary Smith, Martin R Stockler, Sandra Turner, Keen Hun Tai, Henry Woo, Gillian M Duchesne

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

Patterns of health services utilization in the last two weeks of life among cancer patients: Experience in an Australian academic cancer center

Wee Loon Ong, Richard Khor, Mathias Bressel, Phillip Tran, Jo Tedesco, Keen Hun Tai, David Ball, Gillian Duchesne, Farshad Foroudi

Journal article  |  2017  |  Asia-Pacific Journal of Clinical Oncology

Timing of androgen-deprivation therapy in prostate cancer Reply

Gillian M Duchesne, Henry H Woo

Journal article  |  2017  |  The Lancet Oncology

Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

Gillian M Duchesne, Henry H Woo, Madeleine King, Steven J Bowe, Martin R Stockler, Alice Ames, Catherine D'Este, Mark Frydenberg, Andrew Loblaw, Shawn Malone, Jeremy Millar, Keen Hun Tai, Sandra Turner

Journal article  |  2017  |  The Lancet Oncology

Support for the use of objective comorbidity indices in the assessment of noncancer death risk in prostate cancer patients

Sweet Ping Ng, Gillian Duchesne, Keen-Hun Tai, Farshad Foroudi, Gargi Kothari, Scott Williams

Journal article  |  2017  |  Prostate International

Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial

Swetha Sridharan, Allison Steigler, Nigel A Spry, David Joseph, David S Lamb, John H Matthews, Chris Atkinson, Keen-Hun Tai, Gillian Duchesne, David Christie, John Attia, Elizabeth G Holliday, James W Denham

Journal article  |  2016  |  RADIOTHERAPY AND ONCOLOGY

Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial

Penelope Schofield, Karla Gough, Kerryann Lotfi-Jam, Rebecca Bergin, Anna Ugalde, Paul Dudgeon, Wallace Crellin, Kathryn Schubach, Farshard Foroudi, Keen Hun Tai, Gillian Duchesne, Rob Sanson-Fisher, Sanchia Aranda

Journal article  |  2016  |  BMC CANCER

Timing of androgen-deprivation therapy for prostate cancer: still a long way to go Reply

Gillian M Duchesne

Journal article  |  2016  |  The Lancet Oncology

Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

Gillian M Duchesne, Henry H Woo, Julie K Bassett, Steven J Bowe, Catherine D'Este, Mark Frydenberg, Madeleine King, Leo Ledwich, Andrew Loblaw, Shawn Malone, Jeremy Millar, Roger Milne, Rosemary G Smith, Nigel Spry, Martin Stockler, Rodney A Syme, Keen Hun Tai, Sandra Turner

Journal article  |  2016  |  The Lancet Oncology

Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques

Gillian M Duchesne, Annette Haworth, Eric Bone, Hannah Carter, Martin A Ebert, Frank Gagliardi, Adrian Gibbs, Colin Hornby, Andrew Martin, Mark Sidhom, Maree Wood, Michael Jackson

Journal article  |  2016  |  Journal of Medical Imaging and Radiation Oncology

Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data

B Delahunt, L Egevad, JR Srigley, A Steigler, JD Murray, C Atkinson, J Matthews, G Duchesne, NA Spry, D Christie, D Joseph, J Attia, JW Denham

Journal article  |  2015  |  Pathology

Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework

Gillian M Duchesne, Mel Grand, Tomas Kron, Annette Haworth, June Corry, Michael Jackson, Michael Ng, Deidre Besuijen, Hannah E Carter, Andrew Martin, Deborah Schofield, Val Gebski, Joan Torony, Olga Kovacev, Rowena Amin, Bryan Burmeister

Journal article  |  2015  |  Journal of Medical Imaging and Radiation Oncology

The Development of Practice Standards for Radiation Oncology in Australia: A Tripartite Approach

T Kron, M Dwyer, L Smith, A MacDonald, M Pawsey, E Raik, A Arnold, B Hill, GM Duchesne

Journal article  |  2015  |  Clinical Oncology

Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial

James W Denham, Allison Steigler, David Joseph, David S Lamb, Nigel A Spry, Gillian Duchesne, Chris Atkinson, John Matthews, Sandra Turner, Lizbeth Kenny, Keen-Hun Tai, Nirdosh Kumar Gogna, Suki Gill, Hendrick Tan, Rachel Kearvell, Judy Murray, Martin Ebert, Annette Haworth, Angel Kennedy, Brett Delahunt, et al.

Journal article  |  2015  |  Radiotherapy and Oncology

Cognitive existential couple therapy (CECT) in men and partners facing localised prostate cancer: a randomised controlled trial

Jeremy Couper, Anna Collins, Sidney Bloch, Annette Street, Gillian Duchesne, Tessa Jones, James Olver, Anthony Love

Journal article  |  2015  |  BJU International

Tolerability and outcomes of curative radiotherapy in patients aged 85 or more years

Richard C Khor, Mathias Bressel, Jo Tedesco, Keen Hun Tai, David L Ball, Gillian M Duchesne, Helen Farrugia, Wai Kuan Yip, Farshad Foroudi

Journal article  |  2015  |  Medical Journal of Australia

Bladder and other urothelium

Gillian M Duchesne, Shomik Sengupta, Ian D Davis

Book Chapter  |  2015

Radiation Oncology in Australia Reply

Gillian M Duchesne, Sonja Cronje, Sandra L Turner

Journal article  |  2015  |  International Journal of Radiation Oncology*Biology*Physics

Efficacy of High-dose Palliative Radiotherapy for Localised, Castration-resistant Prostate Cancer

R White, R Khor, M Bressel, G Duchesne, S Williams, P Bowden, K Tai, F Foroudi

Journal article  |  2015  |  Clinical Oncology

Researching Depression in Prostate Cancer Patients: Factors, Timing, and Measures

Christopher F Sharpley, Vicki Bitsika, David RH Christie, James W Denham, Gillian M Duchesne, Jeremy W Couper

Journal article  |  2014  |  Journal of Men's Health

The 'Timing of Androgen-Deprivation therapy in incurable prostate cancer' protocol (TOAD) where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trial

Gillian M Duchesne, Henry H Woo

Journal article  |  2014  |  BJU International

Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer

James W Denham, Michael Nowitz, David Joseph, Gillian Duchesne, Nigel A Spry, David S Lamb, John Matthews, Sandra Turner, Chris Atkinson, Keen-Hun Tai, Nirdosh Kumar Gogna, Lizbeth Kenny, Terry Diamond, Richard Smart, David Rowan, Pablo Moscato, Renato Vimieiro, Richard Woodfield, Kevin Lynch, Brett Delahunt, et al.

Journal article  |  2014  |  BJU International

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial

James W Denham, David Joseph, David S Lamb, Nigel A Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen-Hun Tai, David Christie, Lizbeth Kenny, Sandra Turner, Nirdosh Kumar Gogna, Terry Diamond, Brett Delahunt, Christopher Oldmeadow, John Attia, Allison Steigler

Journal article  |  2014  |  The Lancet Oncology

Around the Globe-Radiation Oncology in Australia

Gillian M Duchesne, Sandra L Turner, Sonja Cronje

Journal article  |  2014  |  International Journal of Radiation Oncology*Biology*Physics

Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: Correlation with histopathology

Colin Styles, Nicholas Ferris, Catherine Mitchell, Declan Murphy, Mark Frydenberg, John Mills, John Pedersen, Noelene Bergen, Gillian Duchesne

Journal article  |  2014  |  Journal of Medical Imaging and Radiation Oncology

A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed

Hannah E Carter, Andrew Martin, Deborah Schofield, Gillian Duchesne, Annette Haworth, Colin Hornby, Mark Sidhom, Michael Jackson

Journal article  |  2014  |  Radiotherapy and Oncology

A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial

Maria Pearse, Carol Fraser-Browne, Ian D Davis, Gillian M Duchesne, Richard Fisher, Mark Frydenberg, Annette Haworth, Chakiath Jose, David J Joseph, Tee S Lim, John Matthews, Jeremy Millar, Mark Sidhom, Nigel A Spry, Colin I Tang, Sandra Turner, Scott G Williams, Kirsty Wiltshire, Henry H Woo, Andrew Kneebone

Journal article  |  2014  |  BJU International

Practical implementation of an existing smoking detection pipeline and reduced support vector machine training corpus requirements

Richard Khor, Wai-Kuan Yip, Mathias Bressel, William Rose, Gillian Duchesne, Farshad Foroudi

Journal article  |  2014  |  Journal of the American Medical Informatics Association

Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning

Annette Haworth, Scott Williams, Hayley Reynolds, David Waterhouse, Gillian M Duchesne, Joseph Bucci, David Joseph, Sean Bydder, Martin Ebert

Journal article  |  2013  |  Brachytherapy

Patterns of retreatment with radiotherapy in a large academic centre

Richard Khor, Mathias Bressel, Keen Hun Tai, David Ball, Gillian Duchesne, William Rose, Jo Tedesco, Suki Gill, Claire Fitzpatrick, Farshad Foroudi

Journal article  |  2013  |  Journal of Medical Imaging and Radiation Oncology

Australasian brachytherapy audit: Results of the "end-to-end' dosimetry pilot study

Annette Haworth, Lisa Wilfert, Duncan Butler, Martin A Ebert, Stephen Todd, Joseph Bucci, Gillian M Duchesne, David Joseph, Tomas Kron

Journal article  |  2013  |  Journal of Medical Imaging and Radiation Oncology

Late toxicity and biochemical control in with and without dose escalated image 554 prostate cancer patients treated guided radiotherapy

David Kok, Suki Gill, Mathias Bressel, Keelan Byrne, Tomas Kron, Chris Fox, Gillian Duchesne, Keen Hun Tai, Farshad Foroudi

Journal article  |  2013  |  Radiotherapy and Oncology

Quality improvements in prostate radiotherapy: Outcomes and impact of comprehensive quality assurance during the TROG 03.04 "RADAR' trial

Rachel Kearvell, Annette Haworth, Martin A Ebert, Judy Murray, Ben Hooton, Sharon Richardson, David J Joseph, David Lamb, Nigel A Spry, Gillian Duchesne, James W Denham

Journal article  |  2013  |  Journal of Medical Imaging and Radiation Oncology

Genitourinary Malignancies

GM Duchesne

Book Chapter  |  2013

Direct 2-Arm Comparison Shows Benefit of High-Dose-Rate Brachytherapy Boost vs External Beam Radiation Therapy Alone for Prostate Cancer

Richard Khor, Gillian Duchesne, Keen-Hun Tai, Farshad Foroudi, Sarat Chander, Sylvia Van Dyk, Margaret Garth, Scott Williams

Journal article  |  2013  |  International Journal of Radiation: Oncology - Biology - Physics

A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer

Dragan Ilic, Ben Hindson, Gillian Duchesne, Jeremy L Millar

Journal article  |  2013  |  Journal of Medical Imaging and Radiation Oncology

Cognitive Existential Couple Therapy for newly diagnosed prostate cancer patients and their partners: a descriptive pilot study

Anna L Collins, Anthony W Love, Sidney Bloch, Annette F Street, Gillian M Duchesne, Judy Dunai, Jeremy W Couper

Journal article  |  2013  |  Psycho-Oncology

Faculty of Radiation Oncology, RANZCR

G Duchesne

Journal article  |  2013  |  Cancer Forum

Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial

James W Denham, Chantelle Wilcox, David Joseph, Nigel A Spry, David S Lamb, Keen-Hun Tai, John Matthews, Chris Atkinson, Sandra Turner, David Christie, Nirdosh Kumar Gogna, Lizbeth Kenny, Gillian Duchesne, Brett Delahunt, Patrick McElduff

Journal article  |  2012  |  Lancet Oncology

Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer

James W Denham, Chantelle Wilcox, David S Lamb, Nigel A Spry, Gillian Duchesne, Chris Atkinson, John Matthews, Sandra Turner, Lizheth Kenny, Keen-Hun Tai, Nirdosh Kumar Gogna, Martin Ebert, Brett Delahunt, Patrick McElduff, David Joseph

Journal article  |  2012  |  Radiotherapy and Oncology

Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer

Daisy Mak, Suki Gill, Roxby Paul, Alison Stillie, Annette Haworth, Tomas Kron, Jim Cramb, Kellie Knight, Jessica Thomas, Gillian Duchesne, Farshad Foroudi

Journal article  |  2012  |  Radiation Oncology

Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy

S Gill, J Li, J Thomas, M Bressel, K Thursky, C Styles, KH Tai, GM Duchesne, F Foroudi

Journal article  |  2012  |  British Journal of Radiology

HIGH-DOSE-RATE BRACHYTHERAPY AS A MONOTHERAPY FOR FAVORABLE-RISK PROSTATE CANCER: A PHASE II TRIAL

Maroie Barkati, Scott G Williams, Farshad Foroudi, Keen Hun Tai, Sarat Chander, Sylvia van Dyk, Andrew See, Gillian M Duchesne

Journal article  |  2012  |  International Journal of Radiation: Oncology - Biology - Physics

Electronic portal imaging vs kilovoltage imaging in fiducial marker image-guided radiotherapy for prostate cancer: an analysis of set-up uncertainties

S Gill, J Thomas, C Fox, T Kron, A Thompson, S Chander, S Williams, KH Tai, G Duchesne, F Foroudi

Journal article  |  2012  |  British Journal of Radiology

BENCHMARKING DOSIMETRIC QUALITY ASSESSMENT OF PROSTATE INTENSITY-MODULATED RADIOTHERAPY

Sashendra Senthi, Suki S Gill, Annette Haworth, Tomas Kron, Jim Cramb, Aldo Rolfo, Jessica Thomas, Gillian M Duchesne, Christopher H Hamilton, Daryl Lim Joon, Patrick Bowden, Farshad Foroudi

Journal article  |  2012  |  International Journal of Radiation: Oncology - Biology - Physics

Another form of subgroup to beware

James W Denham, David S Lamb, David Joseph, John Matthews, Chris Atkinson, Nigel A Spry, Gillian Duchesne, Martin Ebert, Allison Steigler, Catherine D'Este

Journal article  |  2011  |  Radiotherapy and Oncology

Interfraction patient motion and implant displacement in prostate high dose rate brachytherapy

CD Fox, T Kron, M Leahy, G Duchesne, S Williams, KH Tai, A Haworth, A Herschtal, F Foroudi

Journal article  |  2011  |  Medical Physics

ONLINE ADAPTIVE RADIOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: RESULTS OF A PILOT STUDY

Farshad Foroudi, Jacky Wong, Tomas Kron, Aldo Rolfo, Annetre Haworth, Paul Roxby, Jessica Thomas, A Herschtal, Daniel Pham, Scott Williams, Keen Hun Tai, Gillian Duchesne

Journal article  |  2011  |  International Journal of Radiation: Oncology - Biology - Physics

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy

Suki Gill, Jessica Thomas, Chris Fox, Tomas Kron, Aldo Rolfo, Mary Leahy, Sarat Chander, Scott Williams, Keen Hun Tai, Gillian M Duchesne, Farshad Foroudi

Journal article  |  2011  |  Radiation Oncology

Localised prostate cancer current treatment opinions

Gillian Duchesne

Journal article  |  2011  |  Australian Family Physician

INTERFRACTION PROSTATE ROTATION DETERMINED FROM IN-ROOM COMPUTERIZED TOMOGRAPHY IMAGES

Rebecca Owen, Tomas Kron, Farshad Foroudi, Alvin Milner, Jennifer Cox, Gillian Duchesne

Journal article  |  2011  |  Medical Dosimetry

PREDICTORS OF ANDROGEN DEPRIVATION THERAPY EFFICACY COMBINED WITH PROSTATIC IRRADIATION: THE CENTRAL ROLE OF TUMOR STAGE AND RADIATION DOSE

Scott Williams, Mark Buyyounouski, Larry Kestin, Gillian Duchesne, Tom Pickles

Journal article  |  2011  |  International Journal of Radiation: Oncology - Biology - Physics

Imaging, radiation oncology and randomised trials: Time for a change?

Gillian M Duchesne, Shih-Chang Wang, Rodney J Hicks

Journal article  |  2011  |  Journal of Medical Imaging and Radiation Oncology

A COMPARISON OF THE PROGNOSTIC VALUE OF EARLY PSA TEST-BASED VARIABLES FOLLOWING EXTERNAL BEAM RADIOTHERAPY, WITH OR WITHOUT PRECEDING ANDROGEN DEPRIVATION: ANALYSIS OF DATA FROM THE TROG 96.01 RANDOMIZED TRIAL

David S Lamb, James W Denham, David Joseph, John Matthews, Chris Atkinson, Nigel A Spry, Gillian Duchesne, Martin Ebert, Allison Steigler, Brett Delahunt, Catherine D'Este

Journal article  |  2011  |  International Journal of Radiation Oncology*Biology*Physics

Tribulations of a prostate cancer trial - Lessons learned from TOAD, a Cancer Council Victoria and Transtasman Radiation Oncology Group trial

Gillian M Duchesne, Henry H Woo, Deborah Howell, Mary Kaimakamis, Evan Kemp

Journal article  |  2010  |  Journal of Medical Imaging and Radiation Oncology

Predictors of psychosocial distress 12 months after diagnosis with early and advanced prostate cancer

Jeremy W Couper, Anthony W Love, Gillian M Duchesne, Sidney Bloch, Michelle Macvean, Judy V Dunai, Marita Scealy, Anthony Costello, David W Kissane

Journal article  |  2010  |  Medical Journal of Australia

Prospective development of an individualised predictive model for treatment coverage using offline cone beam computed tomography surrogate measures in post-prostatectomy radiotherapy

PK Tran, A Haworth, F Foroudi, A Paneghel, AG Herschtal, KH Tai, SG Williams, S Soteriou, M Laferlita, GM Duchesne

Journal article  |  2009  |  Journal of Medical Imaging and Radiation Oncology

Coping Patterns and Psychosocial Distress in Female Partners of Prostate Cancer Patients

Jeremy Couper, Sidney Bloch, Anthony Love, Gillian Duchesne, Michelle MacVean, David Kissane

Journal article  |  2009  |  Psychosomatics

Urethral stricture following high dose rate brachytherapy for prostate cancer

Lisa Sullivan, Scott G Williams, Keen Hun Tai, Farshad Foroudi, L Cleeve, Gillian M Duchesne

Journal article  |  2009  |  Radiotherapy and Oncology

An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry

Warren Toye, Ram Das, Tomas Kron, Rick Franich, Peter Johnston, Gillian Duchesne

Journal article  |  2009  |  Radiotherapy and Oncology

The psychological aftermath of prostate cancer treatment choices: a comparison of depression, anxiety and quality of life outcomes over the 12 months following diagnosis

Jeremy W Couper, Anthony W Love, Judith V Dunai, Gillian M Duchesne, Sidney Bloch, Anthony J Costello, David W Kissane

Journal article  |  2009  |  Medical Journal of Australia

Offline adaptive radiotherapy for bladder cancer using cone beam computed tomography

F Foroudi, J Wong, A Haworth, A Baille, J McAlpine, A Rolfo, T Kron, P Roxby, A Paneghel, S Williams, G Duchesne, KH Tai

Journal article  |  2009  |  Journal of Medical Imaging and Radiation Oncology

Psychosocial adjustment in newly diagnosed prostate cancer

Anthony W Love, Marita Scealy, Sidney Bloch, Gill Duchesne, Jeremy Couper, Michelle Macvean, Anthony Costello, David W Kissane

Journal article  |  2008  |  Australian and New Zealand Journal of Psychiatry

Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3,264 men: Statistical significance without predictive performance

SG Williams, MK Buyyounouski, T Pickles, L Kestin, A Martinez, AL Hanlon, GM Duchesne

Journal article  |  2008  |  International Journal of Radiation: Oncology - Biology - Physics

Thermoluminescence dosimetry for in-vivo verification of high dose rate brachytherapy for prostate cancer

R Das, W Toye, T Kron, S Williams, G Duchesne

Journal article  |  2007  |  Australasian Physical and Engineering Sciences in Medicine

Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer

Scott G Williams, Jeremy MG Taylor, Ning Liu, Yolande Tra, Gillian M Duchesne, Larry L Kestin, Alvaro Martinez, Gary R Pratt, Howard Sandler

Journal article  |  2007  |  International Journal of Radiation Oncology*Biology*Physics

Psychological adjustment of men with prostate cancer: a review of the literature.

Sidney Bloch, Anthony Love, Michelle Macvean, Gill Duchesne, Jeremy Couper, David Kissane

Journal article  |  2007  |  BioPsychoSocial Medicine

OBJECTIVE: Prostate cancer (PCA) is the most common malignancy and a major cause of death in men but, importantly, a substantial p..

Psychosocial adjustment of female partners of men with prostate cancer: A review of the literature

Jeremy Couper, Sidney Bloch, Anthony Love, Michelle Macvean, Gillian M Duchesne, David Kissane

Journal article  |  2006  |  Psycho-Oncology

The psychosocial impact of prostate cancer on patients and their partners

Jeremy W Couper, Sidney Bloch, Anthony Love, Gillian Duchesne, Michelle Macvean, David W Kissane

Journal article  |  2006  |  Medical Journal of Australia

Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group

Nirdosh Kumar Gogna, John HL Matthews, Sandra L Turner, Heidi Mameghan, Gillian M Duchesne, Nigel Spry, Martin P Berry, Jacqui Keller, Lee Tripcony

Journal article  |  2006  |  Radiotherapy and Oncology

How early is early: Androgen deprivation for prostate-specific antigen relapse in prostate cancer

Gillian M Duchesne, Rodney Syme, Deborah Howell

Journal article  |  2006  |  Journal of Clinical Oncology

An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk

SG Williams, GM Duchesne, NK Gogna, JL Millar, T Pickles, GR Pratt, S Turner

Journal article  |  2006  |  International Journal of Radiation: Oncology - Biology - Physics

A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer

JI tang, S WILLIAMS, KH tai, J dean, G DUCHESNE

Journal article  |  2006  |  Brachytherapy

Prioritization of radiotherapy in Australia and New Zealand: where are we now?

G Duchesne

Journal article  |  2005  |  Australasian Radiology

Delayed rectal and urinary symptomatotogy in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation

D Christie, J Denham, A Steigler, D Lamb, S Turner, H Mameghan, D Joseph, J Matthews, I Franklin, C Atkinson, J North, M Poulsen, NA Spry, KH Tai, C Wynne, G Duchesne, O Kovacev, L Francis, A Kramar, C D'Este, et al.

Journal article  |  2005  |  Radiotherapy and Oncology

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: Results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial

JW Denham, A Steigler, DS Lamb, D Joseph, H Mameghan, S Turner, J Matthews, I Franklin, C Atkinson, J North, M Poulsen, D Christie, NA Spry, KH Tai, C Wynne, G Duchesne, O Kovacev, C D'Este

Journal article  |  2005  |  Lancet Oncology

Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.

Annette Haworth, Martin Ebert, Shaun St Clair, Brendan M Carey, Anthony Flynn, David M Bottomley, Gillian M Duchesne, David Joseph, Daniel Ash

Journal article  |  2005  |  Brachytherapy

PURPOSE: To investigate the variability of prostate implant quality indices between three different methods of calculating the pos..

Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer

SG Williams, GM Duchesne, JL Millar, GR Pratt

Journal article  |  2004  |  International Journal of Radiation: Oncology - Biology - Physics

Factors predicting for urinary morbidity following (125)iodine transperineal prostate brachytherapy

SG Williams, JL Millar, GM Duchesne, MJ Dally, PL Royce, RM Snow

Journal article  |  2004  |  Radiotherapy and Oncology

How should we introduce clinical positron emission tomography in the UK? Oncologists need to have a (clearer) view

M Mac Manus, L Peters, G Duchesne, J Zalcberg, RJS Thomas, D Ball, R Hicks

Journal article  |  2004  |  Clinical Oncology

Prostate implant evaluation using tumour control probability - the effect of input parameters

A Haworth, M Ebert, D Waterhouse, D Joseph, G Duchesne

Journal article  |  2004  |  Physics in Medicine and Biology

Assessment of I-125 prostate implants by tumor bioeffect

A Haworth, M Ebert, D Waterhouse, D Joseph, G Duchesne

Journal article  |  2004  |  International Journal of Radiation: Oncology - Biology - Physics

A systematic review of brachytherapy. Is it an effective and safe treatment for localised prostate cancer?

Jenny Doust, Emma Miller, Gillian Duchesne, Michael Kitchener, David Weller

Journal article  |  2004  |  Australian Family Physician

BACKGROUND: Brachytherapy is a promising treatment for prostate cancer as it may have reduced rates of impotence and incontinence...

Trends in the use of androgen deprivation in prostate cancer

EK Salminen, JE Wickstrom, T Vahlberg, GM Duchesne

Journal article  |  2004  |  Acta Oncologica

Clinical prioritisation for curative radiotherapy: A local waiting list initiative

JM Martin, G Ryan, G Duchesne

Journal article  |  2004  |  Clinical Oncology

What defines intermediate-risk prostate cancer? Variability in published prognostic models

SG Williams, JL Millar, MJ Dally, S Sia, W Miles, GM Duchesne

Journal article  |  2004  |  International Journal of Radiation: Oncology - Biology - Physics

Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer

DS Lamb, JW Denham, H Mameghan, D Joseph, S Turner, J Matthews, I Franklin, C Atkinson, J North, M Poulsen, O Kovacev, R Robertson, L Francis, D Christie, NA Spry, KH Tai, C Wynne, G Duchesne

Journal article  |  2003  |  Radiotherapy and Oncology

What to do for prostate cancer patients with a rising PSA? A survey of australian practice

GM Duchesne, JL Millar, V Moraga, M Rosenthal, P Royce, R Snow

Journal article  |  2003  |  International Journal of Radiation: Oncology - Biology - Physics

Outcome, morbidity, and prognostic factors in post-prostatectomy radiotherapy: An Australian multicenter study

GM Duchesne, C Dowling, M Frydenberg, D Joseph, NK Gogna, G Neerhut, S Roberts, N Spry, S Turner, H Woo

Journal article  |  2003  |  Urology

Surgery or radiotherapy for bladder cancer?

G Duchesne

Journal article  |  2002  |  Clinical Oncology

Dose distribution and morbidity after high dose rate brachytherapy for prostate cancer: influence of V150 and V200 parameters.

Gillian M Duchesne, Ram Das, Warren Toye, Andrew See

Journal article  |  2002  |  Australasian Radiology

The purpose of this study is to identify factors predicting morbidity in patients undergoing high dose rate (HDR) brachytherapy bo..

Measurement of lung tumor volumes using three-dimensional computer planning software

P Bowden, R Fisher, M Mac Manus, A Wirth, G Duchesne, M Millward, A McKenzie, J Andrews, D Ball

Journal article  |  2002  |  International Journal of Radiation: Oncology - Biology - Physics